Ferrlecit is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Sodium Ferric Gluconate Complex.
Product ID | 0024-2794_07ce6987-8136-40fd-8cab-84f8ac73a0d0 |
NDC | 0024-2794 |
Product Type | Human Prescription Drug |
Proprietary Name | Ferrlecit |
Generic Name | Sodium Ferric Gluconate Complex |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2014-07-07 |
Marketing Category | NDA / NDA |
Application Number | NDA020955 |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | SODIUM FERRIC GLUCONATE COMPLEX |
Active Ingredient Strength | 13 mg/mL |
Pharm Classes | Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2014-07-07 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020955 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2014-07-07 |
Ingredient | Strength |
---|---|
SODIUM FERRIC GLUCONATE COMPLEX | 12.5 mg/mL |
SPL SET ID: | b25b34ab-9cf1-4a2b-bdf2-5eaf66625999 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0024-2792 | Ferrlecit | sodium ferric gluconate complex |
0024-2794 | Ferrlecit | sodium ferric gluconate complex |
0591-0149 | Sodium Ferric Gluconate Complex | Sodium Ferric Gluconate Complex |
0591-2508 | Sodium Ferric Gluconate Complex in Sucrose | Sodium Ferric Gluconate Complex |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
FERRLECIT 75047697 2408958 Live/Registered |
A. NATTERMANN & CIE. GmbH 1996-01-24 |